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Introduction
Vancomycin-resistant enterococci (VRE) are increasing
in prevalence at many institutions, especially among
patients with co-morbidity conditions that associated
with frequent hospitalisation. It is important to deter-
mine the risk factors for this resistance microorganism as
it will guide the clinician for appropriate antimicrobial
therapy and infection control measures.
Objectives
The descriptive, cross sectional study was carried out to
determine the prevalence and risk factors for vancomycin
resistant enterococci in Kuala Lumpur Hospital (HKL),
Malaysia.
Methods
For 12 months period, antimicrobial susceptibility testing
for enterococci species were performed using disk diffu-
sion method. E-test for vancomycin was proceed for the
isolates that exhibit resistance to vancomycin by disk dif-
fusion method. To identify the risk factors, a question-
naire was completed for all studied patients and the data
were analysed using chi square and multivariate logistic
regression.
Results
The prevalence of VRE among patients in Kuala Lumpur
Hospital was 1%. In chi square analysis, vancomycin usage
(p=0.000, RR, 34.615; 95% CI, 5.796-206.723) showed sig-
nificance risk factor. In multivariate logistic regression
analysis, prolonged hospitalization (p=0.040, RR, 80.194;
95% CI, 1.212-5304.5) and vancomycin use (p=0.009, RR,
18.376; 95% CI, 2.143-165.3) were associated with poten-
tial VRE.
Conclusion
The findings of this study will serve as an alert to the
clinicians of the emergence of infections by VRE and it
will encourage the implemention of appropriate infection
control measures and judicious use of vancomycin in
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